Home・Lista de Ações・Savara Inc

Savara Inc

Fechado

SetorSaúde

5.45 -1.27

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

5.4

Máximo

5.46

Indicadores-chave
By Trading Economics
Rendimento	-5M -37M
Funcionários	70
EBITDA	-3.8M -37M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+104.58% upside

Dividendos
By Acuity
Próximos Ganhos	12 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	64M 1.1B
Abertura anterior	6.72
Fecho anterior	5.45

Sentimento de Notícias

By Acuity

33%

67%

90 / 340 Ranking em Healthcare

Savara Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de jul. de 2026, 20:06 UTC

Event

Savara Inc shares are lower despite the European Patent Office granting a patent for MOLBREEVI, effective through March 2041. The stock remains near its one-month low.

30 de jul. de 2026, 20:09 UTC

Event

Savara Inc shares rise after the European Patent Office grants a patent for MOLBREEVI, providing protection until March 2041.

29 de jul. de 2026, 19:47 UTC

Savara Inc's shares are lower, marking five consecutive sessions of decline. Broader market performance is mixed as traders await the Federal Reserve's interest rate decision.

28 de jul. de 2026, 19:16 UTC

Savara Inc. shares are lower today amid ongoing price weakness. Broader markets like the FTSE 100 and DAX are showing resilience despite this decline.

27 de jul. de 2026, 14:02 UTC

Savara Inc shares are higher during Monday's session, reaching their peak at 9:30 AM ET. No specific news was identified to explain the movement.

24 de jul. de 2026, 20:02 UTC

Savara Inc shares are lower today, continuing a decline since Thursday amid high market volume. Broader market sentiment is affected by recent oil price volatility.

21 de jul. de 2026, 17:41 UTC

Savara Inc. shares are advancing today amid strong trading volume. The broader market is also positive, led by gains in technology stocks.

20 de jul. de 2026, 20:06 UTC

Savara Inc shares are higher, continuing their advance from Friday's close. Broader market sentiment remains mixed amid ongoing geopolitical concerns.

Comparação entre Pares

Variação de preço

Savara Inc Previsão

Preço-alvo

By TipRanks

104.58% parte superior

Previsão para 12 meses

Média 11.17 USD 104.58%

Máximo 16 USD

Mínimo 9 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Savara Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

Comprar

Manter

Vender

Com base em 6 analistas que deram avaliações de ações para Savara Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

90 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.